Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AURIEL-PsO: MSB11022 vs Humira in Plaque Psoriasis
NCT02660580Phase 3Completed
- Sponsor
- Fresenius Kabi
- Start
- Feb 2016
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 3 trial of adalimumab in plaque psoriasis, sponsored by Fresenius Kabi. Started Feb 2016; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02660580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660580.